Shares of GNC (NYSE:GNC) managed to catch a break after a disastrous year so far. Shares have suffered from worries about a general FDA warning about the safety of supplements, increased competition and customer confusion about its pricing strategy.
All of this resulted in comparable sales to plunge as both the CEO and CFO have left the company as well in recent times.